Center Laboratories, Inc.(TW:4123)
NT$28.40+0.15 (+0.53%)
TW:4123
Center Laboratories, Inc. financials statements
NT$28.40
At close:+0.15 (+0.53%)
Center Laboratories, Inc. (4123) Financial Statements
Center Laboratories, Inc. Financial Overview
Center Laboratories, Inc.'s market cap is currently NT$22.38B. The company's EPS TTM is NT$1.19; its P/E ratio is 23.82; and it has a dividend yield of 6.15%. Center Laboratories, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 1.52B | NT$ 1.62B | NT$ 1.39B | NT$ 767.72M | NT$ 500.11M |
| Gross Profit | NT$ 621.26M | NT$ 748.95M | NT$ 618.09M | NT$ 406.27M | NT$ 259.66M |
| Operating Income | NT$ -361.62M | NT$ 234.32M | NT$ 78.54M | NT$ 131.94M | NT$ 1.04B |
| EBITDA | NT$ 11.95B | NT$ -232.41M | NT$ -765.79M | NT$ 232.50M | NT$ 2.73B |
| Net Income | NT$ 9.32B | NT$ -1.10B | NT$ -995.42M | NT$ -575.62M | NT$ 1.82B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 974.21M | NT$ 3.23B | NT$ 4.55B | NT$ 2.56B | NT$ 5.09B |
| Total Assets | NT$ 34.63B | NT$ 25.54B | NT$ 27.00B | NT$ 25.19B | NT$ 30.44B |
| Total Debt | NT$ 4.70B | NT$ 6.53B | NT$ 5.62B | NT$ 3.47B | NT$ 5.27B |
| Net Debt | NT$ 4.47B | NT$ 5.09B | NT$ 3.92B | NT$ 2.68B | NT$ 5.00B |
| Total Liabilities | NT$ 8.14B | NT$ 7.48B | NT$ 6.79B | NT$ 5.94B | NT$ 9.35B |
| Stockholders' Equity | NT$ 26.49B | NT$ 18.05B | NT$ 19.76B | NT$ 19.25B | NT$ 18.94B |
| Cash Flow | |||||
| Free Cash Flow | NT$ -181.05M | NT$ 234.89M | NT$ -1.14B | NT$ -197.43M | NT$ -364.79M |
| Operating Cash Flow | NT$ 27.16M | NT$ 415.71M | NT$ -963.44M | NT$ -189.88M | NT$ -358.14M |
| Investing Cash Flow | NT$ 1.65B | NT$ -757.51M | NT$ -129.01M | NT$ 5.18B | NT$ -655.88M |
| Financing Cash Flow | NT$ -2.88B | NT$ 79.09M | NT$ 2.00B | NT$ -4.46B | NT$ 358.10M |
Currency in TWD

